Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
Preudhomme C, Guilhot J, Nicolini FE, Guerci-Bresler A, Rigal-Huguet F, Maloisel F, Coiteux V, Gardembas M, Berthou C, Vekhoff A, Rea D, Jourdan E, Allard C, Delmer A, Rousselot P, Legros L, Berger M, Corm S, Etienne G, Roche-Lestienne C, Eclache V, Mahon FX, Guilhot F; SPIRIT Investigators; France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC). Preudhomme C, et al. N Engl J Med. 2010 Dec 23;363(26):2511-21. doi: 10.1056/NEJMoa1004095. N Engl J Med. 2010. PMID: 21175313 Free article. Clinical Trial.
Relapsing acute myeloid leukemia beginning with a penile localization.
Martin-Babau J, Tempescul A, Moreau L, Staroz F, Danhier S, Guillerm G, Berthou C, Ianotto JC. Martin-Babau J, et al. Among authors: guillerm g. Am J Hematol. 2011 Feb;86(2):193-4. doi: 10.1002/ajh.21843. Am J Hematol. 2011. PMID: 21264904 Free article. No abstract available.
Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients.
Ianotto JC, Tempescul A, Yan X, Delepine P, Le Calloch R, Hardy E, Eveillard JR, Mugnier N, Berthou C, Guillerm G. Ianotto JC, et al. Among authors: guillerm g. Bone Marrow Transplant. 2012 Jun;47(6):874-6. doi: 10.1038/bmt.2011.189. Epub 2011 Sep 26. Bone Marrow Transplant. 2012. PMID: 21946380 No abstract available.
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
Yakoub-Agha I, Mary JY, Hulin C, Doyen C, Marit G, Benboubker L, Voillat L, Moreau P, Berthou C, Stoppa AM, Maloisel F, Rodon P, Dib M, Pegourie B, Casassus P, Slama B, Damaj G, Zerbib R, Harousseau JL, Mohty M, Facon T; Intergroupe Francophone du Myélome (IFM). Yakoub-Agha I, et al. Eur J Haematol. 2012 Mar;88(3):249-59. doi: 10.1111/j.1600-0609.2011.01729.x. Epub 2012 Jan 4. Eur J Haematol. 2012. PMID: 22023551 Clinical Trial.
Imatinib mesylate induces massive and nonspecific aminoaciduria in CML patients.
Ianotto JC, Tempescul A, Amet Y, Grall P, Dalbies F, Eveillard JR, Guillerm G, Berthou C. Ianotto JC, et al. Among authors: guillerm g. Am J Hematol. 2012 Apr;87(4):437-9. doi: 10.1002/ajh.23113. Epub 2012 Jan 28. Am J Hematol. 2012. PMID: 22287505 Free article. Clinical Trial. No abstract available.
127 results